Erratum: Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase. . Hepatology 2024 Jan 19. doi: 10.1097/HEP.0000000000000759.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Erratum: Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase. Hepatology 2024 Jan 19. doi: 10.1097/HEP.0000000000000759.
PMID: 38271537